BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 14669280)

  • 1. Loss of surface and cyst epithelial basement membranes and preneoplastic morphologic changes in prophylactic oophorectomies.
    Roland IH; Yang WL; Yang DH; Daly MB; Ozols RF; Hamilton TC; Lynch HT; Godwin AK; Xu XX
    Cancer; 2003 Dec; 98(12):2607-23. PubMed ID: 14669280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular events associated with dysplastic morphologic transformation and initiation of ovarian tumorigenicity.
    Yang DH; Smith ER; Cohen C; Wu H; Patriotis C; Godwin AK; Hamilton TC; Xu XX
    Cancer; 2002 May; 94(9):2380-92. PubMed ID: 12015763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic alterations of the extracellular environment of ovarian surface epithelial cells in premalignant transformation, tumorigenicity, and metastasis.
    Capo-Chichi CD; Smith ER; Yang DH; Roland IH; Vanderveer L; Cohen C; Hamilton TC; Godwin AK; Xu XX
    Cancer; 2002 Oct; 95(8):1802-15. PubMed ID: 12365030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of positioning control following Disabled-2 expression in ovarian and breast tumor cells.
    Sheng Z; Sun W; Smith E; Cohen C; Sheng Z; Xu XX
    Oncogene; 2000 Oct; 19(42):4847-54. PubMed ID: 11039902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disabled-2 inactivation is an early step in ovarian tumorigenicity.
    Fazili Z; Sun W; Mittelstaedt S; Cohen C; Xu XX
    Oncogene; 1999 May; 18(20):3104-13. PubMed ID: 10340382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic oophorectomy: a morphologic and immunohistochemical study.
    Schlosshauer PW; Cohen CJ; Penault-Llorca F; Miranda CR; Bignon YJ; Dauplat J; Deligdisch L
    Cancer; 2003 Dec; 98(12):2599-606. PubMed ID: 14669279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies.
    He QY; Zhou Y; Wong E; Ehlen TG; Auersperg N; Chiu JF; Wong AS
    Gynecol Oncol; 2005 Jul; 98(1):68-76. PubMed ID: 15913737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary.
    Bruening W; Giasson BI; Klein-Szanto AJ; Lee VM; Trojanowski JQ; Godwin AK
    Cancer; 2000 May; 88(9):2154-63. PubMed ID: 10813729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-1 and 2 in normal and malignant human ovarian epithelium.
    Li S; Miner K; Fannin R; Carl Barrett J; Davis BJ
    Gynecol Oncol; 2004 Feb; 92(2):622-7. PubMed ID: 14766256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations.
    Deligdisch L; Gil J; Kerner H; Wu HS; Beck D; Gershoni-Baruch R
    Cancer; 1999 Oct; 86(8):1544-50. PubMed ID: 10526284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium.
    Wang W; Bergh A; Damber JE
    Prostate; 2004 Sep; 61(1):60-72. PubMed ID: 15287094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of laminin-5 in serous adenocarcinomas of the ovary.
    Kohlberger P; Muller-Klingspor V; Heinzl H; Obermair A; Breitenecker G; Leodolter S
    Anticancer Res; 2002; 22(6B):3541-4. PubMed ID: 12552953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in ovarian adenocarcinomas.
    Shigemasa K; Tian X; Gu L; Shiroyama Y; Nagai N; Ohama K
    Int J Oncol; 2003 Jan; 22(1):99-105. PubMed ID: 12469191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type IV collagen and CD44v6 expression in benign, malignant primary and metastatic ovarian tumors: correlation with Ki-67 and p53 immunoreactivity.
    Bar JK; Grelewski P; Popiela A; Noga L; Rabczyñski J
    Gynecol Oncol; 2004 Oct; 95(1):23-31. PubMed ID: 15385106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma.
    Hastürk S; Kemp B; Kalapurakal SK; Kurie JM; Hong WK; Lee JS
    Cancer; 2002 Feb; 94(4):1023-31. PubMed ID: 11920472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
    Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
    Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic precursors of ovarian epithelial tumors.
    Resta L; Russo S; Colucci GA; Prat J
    Obstet Gynecol; 1993 Aug; 82(2):181-6. PubMed ID: 8336861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of chronic inflammation-induced basement membrane changes on esophageal carcinogenesis].
    Zhang GH; Su M; Tian DP
    Ai Zheng; 2005 Sep; 24(9):1071-5. PubMed ID: 16159427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA; Shariat SF; Huang HY; Pong RC; Ashfaq R; Shapiro E; Lotan Y; Sagalowsky AI; Wu XR; Hsieh JT
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conditional inactivation of Brca1 in the mouse ovarian surface epithelium results in an increase in preneoplastic changes.
    Clark-Knowles KV; Garson K; Jonkers J; Vanderhyden BC
    Exp Cell Res; 2007 Jan; 313(1):133-45. PubMed ID: 17070800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.